Levi F, La Vecchia C, Randriamiharisoa A, Boyle P
Registre vaudois des tumeurs, Institut universitaire de médecine sociale et préventive, CHUV Falaises 1, Lausanne, Switzerland.
J Cancer Res Clin Oncol. 1991;117(5):497-501. doi: 10.1007/BF01612774.
Trends in mortality from all neoplasms and major cancer sites in Switzerland among populations aged between 20 and 44 years are presented. In men total cancer mortality was approximately constant around 270/10(6) between 1951 and 1965, but declined appreciably thereafter to 217 per million in 1980-1989. The overall fall was 20%. The pattern of trends was similar for women, although a modest decline was already apparent in the earlier calendar period, and the overall fall was 29% (from 303 to 215/10(6)). These favourable trends reflect therapeutic advancements for Hodgkin's disease, leukaemias, testis and (chiefly non-epithelial) ovarian cancer, better control of cervical cancer, the long-term decline in gastric cancer, but also the downward trends in cancer of the intestines and a few less common sites, such as gallbladder and thyroid neoplasms for reasons that are not yet clear. Appreciable rises were observed for lung and other tobacco-related sites in women, for the oral cavity in men and (in earlier calendar periods) cutaneous melanoma in both sexes. Although restricted to a selected number of sites, these rises are discouraging, since the causes of these neoplasms have long been recognized. Somewhat discouraging also is the absence of decline in male lung cancer. These problems notwithstanding, the overall pattern of trends in cancer mortality in young Swiss adults over the last few decades is still reassuring, particularly in comparison with those observed in other European countries, and in the more general framework of the debate on the perspectives of progress in cancer control. Although restricted to a small proportion of all cancer deaths, in fact, trends in young adults offer useful indications on the likely future trends in the same generations in the near future, since they reflect more recent changes in the pattern of exposure. The size of the changes, however, will probably differ, since the prevalent cancers in middle age are different from those in the young.
本文呈现了瑞士20至44岁人群中所有肿瘤及主要癌症部位的死亡率趋势。在男性中,1951年至1965年间,癌症总死亡率约为270/10⁶且大致保持稳定,但此后显著下降,到1980 - 1989年降至217/百万。总体降幅为20%。女性的趋势模式相似,尽管在更早的时间段就已出现适度下降,总体降幅为29%(从303降至215/10⁶)。这些有利趋势反映了霍奇金淋巴瘤、白血病、睾丸癌和(主要是非上皮性)卵巢癌的治疗进展,宫颈癌得到更好控制,胃癌长期下降,以及肠道癌和一些较少见部位(如胆囊和甲状腺肿瘤)的下降趋势,但其原因尚不清楚。在女性中,观察到肺癌及其他与烟草相关部位的死亡率显著上升,男性口腔癌以及(在更早时间段)男女皮肤黑色素瘤死亡率上升。尽管仅限于少数部位,但这些上升令人沮丧,因为这些肿瘤的病因早已明确。男性肺癌死亡率没有下降也有些令人沮丧。尽管存在这些问题,但过去几十年瑞士年轻成年人癌症死亡率的总体趋势模式仍然令人安心,特别是与其他欧洲国家观察到的情况相比,以及在癌症控制进展前景的更广泛辩论框架内。事实上,尽管年轻成年人的趋势仅占所有癌症死亡的一小部分,但它们为同代人近期可能的未来趋势提供了有用的指示,因为它们反映了暴露模式的最新变化。然而,变化的幅度可能不同,因为中年人群中常见的癌症与年轻人不同。